Which of the following agents is not used in the management of erectile dysfunction?
Which drug is known to cause cardiomyopathy?
What is the antidote for paracetamol overdose?
What is the drug of choice for the treatment of acute organophosphate poisoning?
Which of the following aminoglycosides has the highest nephrotoxicity?
Non-oliguric kidney failure occurs with the administration of which of the following drug/s?
What is the antidote for atropine poisoning?
Prolonged administration of sodium nitroprusside can cause which poisoning?
Which of the following drugs are known to cause nephrotoxicity?
Which of the following drugs requires dose adjustment in renal failure?
Explanation: **Explanation:** The management of erectile dysfunction (ED) involves enhancing vasodilation and blood flow to the corpora cavernosa. **Phenylephrine** is a selective **$\alpha_1$-adrenergic agonist** that causes potent vasoconstriction. In clinical practice, it is actually used as the **antidote for priapism** (a prolonged, painful erection) because it constricts the cavernous arteries and promotes venous drainage. Therefore, it is contraindicated in the treatment of ED as it would prevent or reverse an erection. **Analysis of other options:** * **Vardenafil (Option B):** This is a **PDE-5 inhibitor**. By inhibiting the breakdown of cGMP, it promotes smooth muscle relaxation and increased blood flow to the penis. It is a first-line oral treatment for ED. * **Alprostadil (Option D):** This is a synthetic **Prostaglandin E1 (PGE1)** analogue. It increases cAMP levels, leading to smooth muscle relaxation. It is administered via intracavernosal injection or intraurethral pellets. * **Prostaglandin E2 (Option A):** While PGE1 (Alprostadil) is the standard, PGE2 also possesses vasodilatory properties and has been studied/used in various formulations for ED, though it is less common than Alprostadil. **High-Yield Clinical Pearls for NEET-PG:** * **PDE-5 Inhibitors:** Sildenafil, Vardenafil, and Tadalafil (longest acting, "The Weekend Pill"). * **Contraindication:** Never co-administer PDE-5 inhibitors with **Nitrates**, as this can lead to severe, life-threatening hypotension. * **Priapism Management:** Intracavernosal injection of Phenylephrine is the preferred pharmacological treatment to induce detumescence. * **Yohimbine:** An $\alpha_2$ blocker formerly used for ED, though now largely obsolete.
Explanation: **Explanation:** **Trastuzumab** is a monoclonal antibody targeting the **HER2/neu (ErbB2) receptor**, primarily used in HER2-positive breast cancer. The correct answer is Trastuzumab because HER2 receptors are not only present on tumor cells but are also expressed on cardiomyocytes, where they play a crucial role in cell survival and repair. Inhibition of these receptors leads to **Type II Chemotherapy-Induced Cardiotoxicity**, characterized by a dose-independent, often reversible decrease in Left Ventricular Ejection Fraction (LVEF). Unlike Anthracyclines (Type I), it does not typically cause structural damage visible on biopsy. **Analysis of Incorrect Options:** * **Chloroquine:** While primarily known for retinal toxicity (bull’s eye maculopathy) and QT prolongation, it is not a classic cause of cardiomyopathy in the context of standard oncological or rheumatological monitoring compared to Trastuzumab. * **Methotrexate:** Its primary dose-limiting toxicities are bone marrow suppression (myelosuppression), mucosal ulceration, and hepatotoxicity (fibrosis). It is not associated with cardiomyopathy. * **Pemetrexed:** An antifolate used in lung cancer; its main side effects include myelosuppression and skin rashes (prevented by dexamethasone). It lacks significant cardiotoxic potential. **Clinical Pearls for NEET-PG:** * **Monitoring:** Baseline and periodic **Echocardiography or MUGA scans** are mandatory for patients on Trastuzumab to monitor LVEF. * **Synergy:** The risk of heart failure increases significantly when Trastuzumab is used concurrently with **Anthracyclines (Doxorubicin)**. * **Reversibility:** Type II cardiotoxicity (Trastuzumab) is generally reversible upon drug discontinuation, whereas Type I (Anthracyclines) is dose-dependent and irreversible.
Explanation: ### Explanation **Correct Answer: A. N-acetylcysteine (NAC)** **Mechanism of Action:** Paracetamol (Acetaminophen) is normally metabolized in the liver. A small portion is converted by Cytochrome P450 enzymes into a highly reactive toxic metabolite called **NAPQI** (*N-acetyl-p-benzoquinone imine*) [2]. In therapeutic doses, NAPQI is neutralized by **glutathione**. In an overdose, glutathione stores are depleted, leading to NAPQI-induced hepatic necrosis. **N-acetylcysteine (NAC)** acts as an antidote by: 1. Replenishing hepatic glutathione stores. 2. Acting as a glutathione substitute to directly detoxify NAPQI [3]. 3. Serving as a precursor for sulfate conjugation. **Analysis of Incorrect Options:** * **B. Methylene blue:** This is the antidote for **Methemoglobinemia** (caused by drugs like nitrates, sulfonamides, or local anesthetics). * **C. EDTA (Ethylene Diamine Tetra-acetic Acid):** This is a chelating agent used primarily for **Lead poisoning**. * **D. No effective antidote known:** Incorrect, as NAC is highly effective, especially when administered within 8–10 hours of ingestion [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Rumack-Matthew Nomogram:** Used to determine the need for NAC treatment based on plasma paracetamol levels and time since ingestion (valid only for single acute ingestions) [3]. * **Timing:** NAC is most effective if given within **8 hours** [1]. However, it should be administered even if the patient presents late (>24 hours) as it improves survival in fulminant hepatic failure. * **Route:** Can be given Orally (72-hour protocol) or Intravenously (21-hour protocol) [1]. * **Toxicity Marker:** The earliest sign of toxicity is often nausea/vomiting, but **ALT/AST elevation** is the most specific indicator of hepatotoxicity [4].
Explanation: **1. Why Atropine is the Correct Answer:**Acute organophosphate (OP) poisoning causes an "acetylcholine storm" by irreversibly inhibiting the enzyme acetylcholinesterase. This leads to life-threatening overstimulation of muscarinic receptors (causing bradycardia, bronchospasm, and excessive secretions). **Atropine** is a competitive muscarinic antagonist and is the **specific physiological antidote**. It is the drug of choice because it directly reverses the killer symptoms (bronchoconstriction and bradycardia) [1]. In emergencies, it is titrated until "atropinization" (clear lungs and heart rate >80 bpm) is achieved. **2. Why Other Options are Incorrect:** * **Pralidoxime (B):** While Pralidoxime is a "cholinesterase regenerator" [2, 3], it is considered an **adjuvant** to Atropine [1]. It works only if administered before "aging" of the enzyme occurs [2, 3]. It does not cross the blood-brain barrier effectively [3] and cannot be used alone to manage acute respiratory distress. With severe toxicities from lipid-soluble agents, it is necessary to continue treatment with atropine and pralidoxime for a week or longer [4]. * **Neostigmine (C):** This is an acetylcholinesterase inhibitor itself. Giving it would worsen the poisoning by further increasing acetylcholine levels. * **d–Tubocurarine (D):** This is a skeletal muscle relaxant. While it blocks nicotinic receptors, it has no effect on the life-threatening muscarinic symptoms and can cause respiratory paralysis. **3. NEET-PG High-Yield Pearls:** * **Mnemonic for Muscarinic symptoms:** **DUMBELS** (Diarrhea, Urination, Miosis, Bradycardia/Bronchospasm, Emesis, Lacrimation, Salivation). * **Atropine vs. Oximes:** Atropine reverses *muscarinic* effects [1]; Oximes (Pralidoxime) reverse *nicotinic* effects (muscle weakness/paralysis) [1]. * **Monitoring:** The best indicator of adequate atropinization is the **drying of pulmonary secretions** and an increase in heart rate, *not* pupillary dilation. * **Contraindication:** Avoid Succinylcholine in OP poisoning as its metabolism is inhibited, leading to prolonged paralysis.
Explanation: ### Explanation Aminoglycosides are notorious for causing **Nephrotoxicity** and **Ototoxicity**. The mechanism of nephrotoxicity involves the accumulation of the drug in the proximal convoluted tubule (PCT) cells, leading to acute tubular necrosis (ATN). **Why Neomycin is the correct answer:** Neomycin is the **most nephrotoxic** aminoglycoside. Its potential for systemic toxicity is so high that it is never administered parenterally. It is restricted to topical applications (skin/eye) or oral administration for local gut action (e.g., hepatic coma or bowel preparation), as it is poorly absorbed from the GIT. **Analysis of Incorrect Options:** * **Streptomycin:** It is considered the **least nephrotoxic** among the aminoglycosides but is highly vestibulotoxic. * **Amikacin:** While it can cause nephrotoxicity, its potential is significantly lower than Neomycin and Gentamicin. It is often reserved for multi-drug resistant infections. * **Paromomycin:** Used primarily for intestinal amoebiasis and leishmaniasis; while it carries a risk of toxicity if absorbed, it does not reach the nephrotoxic potential of Neomycin. **High-Yield NEET-PG Pearls:** * **Order of Nephrotoxicity:** Neomycin > Gentamicin > Tobramycin > Amikacin > Streptomycin. * **Order of Ototoxicity (Cochlear):** Neomycin > Amikacin > Kanamycin. * **Order of Ototoxicity (Vestibular):** Streptomycin > Gentamicin. * **Clinical Sign:** Aminoglycoside-induced nephrotoxicity is usually **reversible** upon drug discontinuation, whereas ototoxicity is often **irreversible**. * **Monitoring:** Therapeutic Drug Monitoring (TDM) is essential for aminoglycosides to prevent toxicity, especially in patients with pre-existing renal impairment.
Explanation: **Explanation:** **Non-oliguric acute kidney injury (AKI)** is characterized by a significant decline in glomerular filtration rate (GFR) and an increase in serum creatinine, but without the typical reduction in urine output (urine volume remains >400 mL/day). This occurs because the primary insult is to the renal tubules, impairing their ability to concentrate urine and reabsorb water, even as the filtration rate drops. **Analysis of Options:** * **Gentamicin (Aminoglycosides):** These are classic causes of non-oliguric AKI. They accumulate in the proximal convoluted tubule (PCT) cells, causing oxidative stress and necrosis. Patients typically maintain urine output but show a rise in creatinine after 5–7 days of therapy. * **Cisplatin:** This potent platinum-based chemotherapeutic agent is highly nephrotoxic. It causes damage to the S3 segment of the PCT and the thick ascending limb. The resulting polyuria or non-oliguria is due to a defect in the urinary concentrating mechanism. * **Ifosfamide:** An alkylating agent (oxazaphosphorine) that is notorious for causing proximal tubular dysfunction. It can lead to **Fanconi Syndrome** and non-oliguric renal failure, often exacerbated by its metabolite, acrolein. **Conclusion:** Since all three drugs are well-documented causes of toxic tubular injury that presents without oliguria, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** 1. **Amphotericin B** is another classic cause of non-oliguric AKI and distal Renal Tubular Acidosis (Type 1). 2. **Prevention:** Cisplatin-induced nephrotoxicity is minimized using **Amifostine** (a cytoprotective agent) and aggressive hydration with chloride-containing solutions. 3. **Ifosfamide/Cyclophosphamide:** Hemorrhagic cystitis caused by these drugs is prevented by **MESNA** (Mercaptoethane sulfonate), which neutralizes acrolein in the bladder. 4. Non-oliguric AKI generally has a **better prognosis** and lower mortality rate compared to oliguric AKI.
Explanation: **Physostigmine** is the specific antidote for atropine (anticholinergic) poisoning [1]. Atropine acts as a competitive antagonist at muscarinic receptors. Physostigmine is a **tertiary amine** acetylcholinesterase (AChE) inhibitor. Unlike other carbamates (like Neostigmine), it is lipid-soluble and **crosses the blood-brain barrier**. This allows it to reverse both peripheral symptoms (tachycardia, dry skin) and central anticholinergic effects (delirium, hallucinations, seizures) [1].**Analysis of Incorrect Options:** * **A. Flumazenil:** A competitive GABA-A receptor antagonist used specifically to reverse **Benzodiazepine** overdose.* **C. Naloxone:** A competitive opioid receptor antagonist used to reverse respiratory depression in **Opioid** toxicity.* **D. NaHCO3 (Sodium Bicarbonate):** Used to treat **Tricyclic Antidepressant (TCA)** toxicity. While TCAs have anticholinergic effects, NaHCO3 is primarily given to stabilize the myocardium by overcoming the fast sodium channel blockade.**High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Atropine Toxicity:** "Hot as a hare (fever), Red as a beet (flushing), Dry as a bone (anhidrosis), Blind as a bat (mydriasis), Mad as a hatter (delirium)."* **Contraindication:** Physostigmine should be avoided in TCA overdose as it can worsen cardiac conduction delays and precipitate asystole.* **Neostigmine vs. Physostigmine:** Remember that Neostigmine is a quaternary ammonium and does *not* cross the BBB; hence, it is ineffective for the CNS symptoms of atropine poisoning.
Explanation: **Explanation:** **Sodium Nitroprusside (SNP)** is a potent, rapid-acting vasodilator used in hypertensive emergencies. Its chemical structure consists of a ferrous iron core complexed with five **cyanide (CN⁻) groups** and one nitrosyl group. **Why Cyanide is the Correct Answer:** When SNP enters the bloodstream, it reacts with hemoglobin and sulfhydryl groups in erythrocytes, releasing nitric oxide (for vasodilation) and **five cyanide ions**. Normally, the liver enzyme **rhodanese** detoxifies cyanide by converting it into thiocyanate using sulfur donors (thiosulfate). However, prolonged administration or high doses can exhaust sulfur stores, leading to cyanide accumulation. Cyanide inhibits mitochondrial cytochrome oxidase, causing cellular hypoxia and metabolic acidosis. **Why Other Options are Incorrect:** * **Methanol:** Poisoning typically occurs via ingestion of adulterated alcohol, leading to formic acid accumulation and retinal damage. It is not a byproduct of SNP metabolism. * **Arsenic:** Toxicity usually results from environmental exposure or contaminated groundwater, affecting multi-organ systems through enzyme inhibition (pyruvate dehydrogenase). * **Phenol:** Toxicity is generally associated with industrial exposure or chemical burns; it is not related to nitroprusside degradation. **High-Yield Clinical Pearls for NEET-PG:** * **Antidote for SNP-induced Cyanide Toxicity:** Sodium Thiosulfate (provides sulfur donors) or Hydroxocobalamin (binds cyanide to form Vitamin B12). * **Monitoring:** Long-term use can also lead to **Thiocyanate toxicity** (presenting as psychosis or seizures), especially in patients with renal failure. * **Storage:** SNP is light-sensitive; the infusion bag must be wrapped in opaque foil to prevent photodegradation.
Explanation: ### Explanation **Correct Answer: A. Gentamicin and Phenacetin** **1. Why the Correct Answer is Right:** Nephrotoxicity is a major dose-limiting side effect for several drug classes. * **Gentamicin:** As an **Aminoglycoside**, it is filtered by the glomerulus and actively reabsorbed by the proximal tubule cells. It accumulates in the renal cortex, leading to **Acute Tubular Necrosis (ATN)**. It typically presents as non-oliguric renal failure. * **Phenacetin:** This is a classic example of a drug causing **Analgesic Nephropathy**. Chronic use leads to **Renal Papillary Necrosis** and chronic interstitial nephritis. Due to this severe toxicity, phenacetin has been withdrawn from many markets. **2. Why the Other Options are Wrong:** * **Cloxacillin (Options B & C):** While some penicillins (like Methicillin) are notorious for causing *Acute Interstitial Nephritis (AIN)*, Cloxacillin is not a primary nephrotoxin. It is mainly associated with hypersensitivity reactions rather than direct dose-dependent renal damage. * **Erythromycin (Option D):** This is a Macrolide antibiotic. Its primary toxicity is **hepatotoxicity** (specifically cholestatic jaundice) and GI upset. It is not considered nephrotoxic; in fact, it is often used as a safe alternative in patients with renal impairment. **3. NEET-PG High-Yield Clinical Pearls:** * **Aminoglycoside Monitoring:** To minimize Gentamicin toxicity, clinicians monitor **trough levels** and often use **Once-Daily Dosing** (Extended Interval Dosing) to take advantage of the post-antibiotic effect while allowing renal washout. * **Other Nephrotoxic "Must-Knows":** Amphotericin B (causes distal RTA), Cisplatin (prevented with Amifostine/hydration), and Contrast Media. * **Analgesic Nephropathy Triad:** Chronic interstitial nephritis, papillary necrosis, and increased risk of transitional cell carcinoma of the renal pelvis.
Explanation: **Explanation:** The correct answer is **Streptomycin**. **1. Why Streptomycin is correct:** Streptomycin is an **Aminoglycoside**. Aminoglycosides are highly polar, water-soluble molecules that are excreted almost entirely unchanged by the kidneys via glomerular filtration. In renal failure, the clearance of these drugs decreases significantly, leading to accumulation and a high risk of dose-dependent toxicities, specifically **nephrotoxicity** and **ototoxicity**. Therefore, dose adjustment (either by reducing the dose or increasing the dosing interval) is mandatory based on Creatinine Clearance (CrCl). **2. Why the other options are incorrect:** * **Cefoperazone:** This is a third-generation cephalosporin that is primarily excreted through **bile**. It is one of the few cephalosporins (along with Ceftriaxone) that does not require dose adjustment in renal failure. * **Doxycycline:** Unlike other tetracyclines, Doxycycline is excreted primarily via the **gastrointestinal tract** (fecal excretion). It is the tetracycline of choice in patients with renal impairment. * **Rifampicin:** This drug is metabolized by the **liver** and excreted mainly through bile. It does not require dose modification in patients with renal dysfunction. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for drugs safe in renal failure:** "DORC" – **D**oxycycline, **O**perazone (Cefoperazone), **R**ifampicin, **C**eftriaxone. * **Aminoglycoside Monitoring:** In clinical practice, the "Nomogram" method or Therapeutic Drug Monitoring (TDM) is used to adjust doses. * **Other drugs requiring adjustment:** Digoxin, Lithium, Vancomycin, and Ethambutol are frequently tested "must-adjust" drugs in renal failure.
Principles of Clinical Pharmacology
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Drug Toxicity and Overdose
Practice Questions
Antidotes and Their Applications
Practice Questions
Management of Drug Poisoning
Practice Questions
Drug-Induced Liver Injury
Practice Questions
Drug-Induced Kidney Injury
Practice Questions
Drug-Induced Blood Dyscrasias
Practice Questions
Drug-Induced QT Prolongation
Practice Questions
Pharmacovigilance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free